在新辅助疗法后瘤微环境中增强补充表达:胰腺管道腺癌免疫调节和存活的影响
Xiaofei Zhang1,2, Ruoxin Lan3, Yongjun Liu1,4
1Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI.
Research square
|May 27, 2024
概括
新辅助疗法 (NAT) 在胰腺管腺癌 (PDAC) 瘤中增强补充通路,通过减少免疫抑制来改善患者的生存率. 这表明补充动态作为治疗反应的潜在生物标志物.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 胰腺管道腺癌 (PDAC) 治疗越来越多地使用新辅助疗法 (NAT).
- NAT对PDAC癌细胞和瘤微环境 (TME) 的确切影响仍然不完全理解.
- 这项研究调查了NAT对PDAC细胞和微环境组件的差异性影响.
结论:
- NAT在TME内增强补充剂的产生和信号,与PDAC中免疫抑制的降低相关.
- 局部补充动态显示为预后和治疗响应评估NAT治疗PDAC的生物标志物具有前景.
- 这些见解可以指导PDAC的未来治疗策略.
更多相关视频
08:30Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry
Published on: October 9, 2018
12.3K
10:11Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue
Published on: January 3, 2013
23.1K
相关概念视频
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
01:27Tumor Immunotherapy
515
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
515